Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-06, Stock:LLY, The news for the past five days is as follows:
2019-07-30: NEWS1: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS2: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS3: Eli Lilly's Solid Q2 Results: What You'll Want to Know.NEWS4: Eli Lilly's Solid Q2 Results: What You'll Want to Know.NEWS5: Why Pharma Giant Merck Expects Its Best Sales Growth In 9 Years.NEWS6: Eli Lilly&apos;s Solid Q2 Results: What You&apos;ll Want to Know.NEWS7: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS8: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS9: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS10: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS11: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS12: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS13: Merck Shares Rise on Strong Sales Growth.NEWS14: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS15: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS16: Economic and Earnings Date Deluge.NEWS17: Economic and Earnings Date Deluge.NEWS18: 6 Stock Gurus See Bargains Amid Market Highs.NEWS19: Economic and Earnings Date Deluge.NEWS20: Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More.NEWS21: Eli Lilly (LLY) Tops Q2 Earnings Estimates.NEWS22: Eli Lilly (LLY) Tops Q2 Earnings Estimates.NEWS23: Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN.NEWS24: Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN.NEWS25: Eli Lilly tops profit estimates on boost from diabetes drugs.NEWS26: Eli Lilly lifts outlook after boost from diabetes drug.NEWS27: Eli Lilly Reports Q2 Earnings Beat.NEWS28: Eli Lilly (LLY) Tops Q2 Earnings Estimates.NEWS29: Eli Lilly Tops Q2 Profit Forecast, Lifts 2019 Guidance, as Trulicity Sales Surge.NEWS30: The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings.NEWS31: UPDATE 3-Newer drugs help Eli Lilly top Wall Street quarterly profit estimate.NEWS32: Eli Lilly tops revenue estimates on diabetes drug boost.NEWS33: Eli Lilly's stock jumps after profit and revenue beats, raised guidance.NEWS34: Lilly Reports Second-Quarter 2019 Financial Results, Raises 2019 EPS Guidance.NEWS35: Lilly's Verzenio® (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2.
2019-07-31: NEWS1: Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates.NEWS2: Amgen (AMGN) Q2 Earnings & Sales Beat, New Drugs Shine.NEWS3: Amgen (AMGN) Q2 Earnings & Sales Beat, New Drugs Shine.NEWS4: Amgen (AMGN) Q2 Earnings & Sales Beat, New Drugs Shine.NEWS5: Eli Lilly and Company (LLY) Q2 2019 Earnings Call Transcript.NEWS6: Eli Lilly and Company (LLY) Q2 2019 Earnings Call Transcript.NEWS7: Eli Lilly and Company (LLY) Q2 2019 Earnings Call Transcript.
2019-08-01: NEWS1: United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y.NEWS2: United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y.NEWS3: United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y.NEWS4: What Should Investors Know About Eli Lilly and Company's (NYSE:LLY) Growth?.NEWS5: FOCUS-Blue-blooded crabs at heart of pharma dispute on drug testing.
2019-08-02: NEWS1: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.NEWS2: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.NEWS3: Noteworthy ETF Outflows: MTUM, DHR, CRM, LLY.NEWS4: Noteworthy ETF Outflows: MTUM, DHR, CRM, LLY.NEWS5: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.NEWS6: Edited Transcript of LLY earnings conference call or presentation 30-Jul-19 1:00pm GMT.
2019-08-05: NEWS1: Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates.NEWS2: Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates.NEWS3: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS4: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS5: Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2.NEWS6: Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2.NEWS7: Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates.NEWS8: Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2.NEWS9: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS10: Eli Lilly Announces Positive Results For Emgality.NEWS11: Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments.

Answer: Rise